Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-25-122504·Shen Ethan PhD
Schedule 13G ownership disclosure
YD BIO LTD CMN
Ordinary Shares, par value of US$0.0001 per share · CUSIP: G98301107
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ethan Shen
Shares: 54,345,011.00 · Class: 77.1%
- YD Biopharma Holding Limited
Shares: 43,120,858.00 · Class: 61.1%
- EG Biomed Limited
Shares: 11,224,153.00 · Class: 15.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-122504
- Form type
- SCHEDULE 13G
- Filer
- Shen Ethan PhD
- CIK
- CIK 2099921
- Filed
- Dec 16, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership